Home/Filings/4/0000905148-24-001625
4//SEC Filing

Jayagopal Ashwath 4

Accession 0000905148-24-001625

CIK 0001228627other

Filed

May 23, 8:00 PM ET

Accepted

May 24, 4:07 PM ET

Size

4.5 KB

Accession

0000905148-24-001625

Insider Transaction Report

Form 4
Period: 2024-05-22
Jayagopal Ashwath
Chief Scientific & Dev. Ofc.
Transactions
  • Purchase

    Common Stock

    2024-05-22$1.76/sh+3,500$6,17878,500 total

Documents

1 file

Issuer

Ocuphire Pharma, Inc.

CIK 0001228627

Entity typeother

Related Parties

1
  • filerCIK 0002008983

Filing Metadata

Form type
4
Filed
May 23, 8:00 PM ET
Accepted
May 24, 4:07 PM ET
Size
4.5 KB